Plain-English translation of NCT05493514 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study is testing a robotic device called the G-EO system that helps guide your feet and legs during walking therapy. Researchers want to understand which patients benefit most from this robot-assisted walking treatment and what factors predict success. You would receive at least 10 sessions of therapy using this device while researchers measure your progress.
While robotic walking devices like the G-EO system show promise for helping people with neurological diseases improve their balance and gait, doctors don't yet know which patients will benefit most or what treatment settings work best. This study aims to identify those predictors so treatment can be better personalized.
You likely qualify if…
You likely don't qualify if…
You would attend at least 10 therapy sessions using the G-EO robotic walking system, visiting at least twice per week. During each session, the robot guides your feet and legs through walking movements while a physiotherapist adjusts the difficulty and support level based on your needs. Researchers would measure your walking ability, balance, and other outcomes before treatment begins and after you complete your sessions.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy
Sponsor
Fondazione Don Carlo Gnocchi ETS
Enrollment target
~260 participants
Started
May 2022
Primary completion
April 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2022.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Davide Cattaneo, PhD
Fondazione Don Carlo Gnocchi ETS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.